Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology

The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of psychopharmacology (Oxford) Vol. 30; no. 6; pp. 495 - 553
Main Authors:	Goodwin, GM, Haddad, PM, Ferrier, IN, Aronson, JK, Barnes, TRH, Cipriani, A, Coghill, DR, Fazel, S, Geddes, JR, Grunze, H, Holmes, EA, Howes, O, Hudson, S, Hunt, N, Jones, I, Macmillan, IC, McAllister-Williams, H, Miklowitz, DR, Morriss, R, Munafò, M, Paton, C, Sahakian, BJ, Saunders, KEA, Sinclair, JMA, Taylor, D, Vieta, E, Young, AH
Format:	Journal Article
Language:	English
Published:	London, England SAGE Publications 01-06-2016 Sage Publications Ltd
Subjects:	antidepressants Antidepressive Agents - therapeutic use antipsychotics Bipolar disorder Bipolar Disorder - diagnosis Bipolar Disorder - therapy Clinical trials cognitive behaviour therapy Combined Modality Therapy Consensus Decision making Diagnosis, Differential evidence-based guidelines Evidence-Based Medicine Feedback Guidelines Humans lithium Medication Adherence Medicin och hälsovetenskap mood stabilizers Patient Education as Topic Practice Guidelines as Topic psychoeducation Psychopharmacology Secondary Prevention treatment treatment lithium cognitive behaviour therapy evidence-based guidelines antipsychotics Bipolar disorder psychoeducation antidepressants mood stabilizers
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The British Association for Psychopharmacology guidelines specify the scope and targets of treatment for bipolar disorder. The third version is based explicitly on the available evidence and presented, like previous Clinical Practice Guidelines, as recommendations to aid clinical decision making for practitioners: it may also serve as a source of information for patients and carers, and assist audit. The recommendations are presented together with a more detailed review of the corresponding evidence. A consensus meeting, involving experts in bipolar disorder and its treatment, reviewed key areas and considered the strength of evidence and clinical implications. The guidelines were drawn up after extensive feedback from these participants. The best evidence from randomized controlled trials and, where available, observational studies employing quasi-experimental designs was used to evaluate treatment options. The strength of recommendations has been described using the GRADE approach. The guidelines cover the diagnosis of bipolar disorder, clinical management, and strategies for the use of medicines in short-term treatment of episodes, relapse prevention and stopping treatment. The use of medication is integrated with a coherent approach to psychoeducation and behaviour change.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0269-8811 1461-7285 1461-7285
DOI:	10.1177/0269881116636545